Pancreatic Brsk2 amplifies parasympathetic signals to promote type 2 diabetes

The parasympathetic nervous system (PNS) modulates postprandial glucose metabolism via innervating pancreas; however, its significance in the pathogenesis of type 2 diabetes (T2DM) remains unclear. Here we show that brain-specific serine/threonine-protein kinase 2 (Brsk2), accumulated in obese mouse islets, responds to PNS activation and initiates pre-absorptive insulin release. In inducible mouse models, excessive Brsk2 amplifies parasympathetic signaling to β cells and increases their secretion, ensuing insulin resistance and T2DM. Conversely, Brsk2 inhibition prevents and treats HFD-induced metabolic abnormities via avoiding β-cell oversecretion. Mechanistically, parasympathetic acetylcholine activates cholinergic receptor M3 (Chrm3), then Chrm3 recruits and stabilizes Brsk2, which in turn phosphorylates phospholipase A2 activating protein (Plaa). A Chrm3-Brsk2-Plaa axis stimulates β-cell hypersecretion during both pre-absorptive and absorptive stages in HFD-feeding mice, thus imposing insulin resistance and β-cell dysfunction. Blocking parasympathetic signaling to β cells by Brsk2 protein restoration, autonomic mediation drugs, or vagotomy restricted diabetes development. Moreover, three human BRSK2 variants are associated with hyperinsulinemia, insulin resistance, and T2DM in the Chinese population. These findings reveal that Brsk2 links parasympathetic nervous system to nutrition-overload induced T2DM.

[1]  H. Berthoud,et al.  Gut-brain communication and obesity: understanding functions of the vagus nerve. , 2021, The Journal of clinical investigation.

[2]  T. S. Kobilka,et al.  Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist , 2020, Proceedings of the National Academy of Sciences.

[3]  Zhuhao Wu,et al.  A 3D atlas of the dynamic and regional variation of pancreatic innervation in diabetes , 2020, Science Advances.

[4]  G. Shulman,et al.  The integrative biology of type 2 diabetes , 2019, Nature.

[5]  Yunxia Zhu,et al.  SAD-A, a downstream mediator of GLP-1 signaling, promotes the phosphorylation of Bad S155 to regulate in vitro β-cell functions. , 2019, Biochemical and biophysical research communications.

[6]  Martin E. Hess,et al.  Food Perception Primes Hepatic ER Homeostasis via Melanocortin-Dependent Control of mTOR Activation , 2018, Cell.

[7]  G. Rutter,et al.  The α-cell in diabetes mellitus , 2018, Nature Reviews Endocrinology.

[8]  E. Cerasi,et al.  Effects of proinsulin misfolding on β‐cell dynamics, differentiation and function in diabetes , 2018, Diabetes, obesity & metabolism.

[9]  P. Berggren,et al.  Diet-induced β-cell insulin resistance results in reversible loss of functional β-cell mass , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Y. Bao,et al.  Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes? , 2018, Cardiovascular Diabetology.

[11]  James D. Johnson,et al.  Mild Suppression of Hyperinsulinemia to Treat Obesity and Insulin Resistance , 2018, Trends in Endocrinology & Metabolism.

[12]  E. Feldman,et al.  Neurological consequences of obesity , 2017, The Lancet Neurology.

[13]  Mark T. Handley,et al.  PLAA Mutations Cause a Lethal Infantile Epileptic Encephalopathy by Disrupting Ubiquitin-Mediated Endolysosomal Degradation of Synaptic Proteins , 2017, American journal of human genetics.

[14]  M. McCarthy,et al.  Exposing the exposures responsible for type 2 diabetes and obesity , 2016, Science.

[15]  D. Olson,et al.  Functional identification of a neurocircuit regulating blood glucose , 2016, Proceedings of the National Academy of Sciences.

[16]  Jue Wang,et al.  Structural insight into the mechanism of synergistic autoinhibition of SAD kinases , 2015, Nature Communications.

[17]  B. Marsh,et al.  Pancreatic β-Cell Adaptive Plasticity in Obesity Increases Insulin Production but Adversely Affects Secretory Function , 2015, Diabetes.

[18]  G. Bertrand,et al.  β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1* , 2015, The Journal of Biological Chemistry.

[19]  E. Deneris,et al.  Gαi/o-coupled receptor signaling restricts pancreatic β-cell expansion , 2015, Proceedings of the National Academy of Sciences.

[20]  R. Rodriguez-Diaz,et al.  Neural control of the endocrine pancreas. , 2014, Best practice & research. Clinical endocrinology & metabolism.

[21]  A. Merlo,et al.  MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomas. , 2014, The Journal of clinical investigation.

[22]  M. Foretz,et al.  Nervous glucose sensing regulates postnatal β cell proliferation and glucose homeostasis. , 2014, The Journal of clinical investigation.

[23]  Xiao Han,et al.  SAD-A and AMPK kinases: The “yin and yang” regulators of mTORC1 signaling in pancreatic β cells , 2013, Cell cycle.

[24]  D. Bleich,et al.  MicroRNA-24/MODY Gene Regulatory Pathway Mediates Pancreatic β-Cell Dysfunction , 2013, Diabetes.

[25]  J. Sanes,et al.  SAD-A kinase controls islet β-cell size and function as a mediator of mTORC1 signaling , 2013, Proceedings of the National Academy of Sciences.

[26]  J. Sanes,et al.  SAD Kinases Sculpt Axonal Arbors of Sensory Neurons through Long- and Short-Term Responses to Neurotrophin Signals , 2013, Neuron.

[27]  J. Sanes,et al.  SAD-A Potentiates Glucose-Stimulated Insulin Secretion as a Mediator of Glucagon-Like Peptide 1 Response in Pancreatic β Cells , 2013, Molecular and Cellular Biology.

[28]  Xiao Han,et al.  Synapses of Amphids Defective (SAD-A) Kinase Promotes Glucose-stimulated Insulin Secretion through Activation of p21-activated Kinase (PAK1) in Pancreatic β-Cells* , 2012, The Journal of Biological Chemistry.

[29]  A. Vinik,et al.  Autonomic imbalance: prophet of doom or scope for hope? , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[30]  K. Teff,et al.  How neural mediation of anticipatory and compensatory insulin release helps us tolerate food , 2011, Physiology & Behavior.

[31]  L. Groop,et al.  Overexpression of Alpha2A-Adrenergic Receptors Contributes to Type 2 Diabetes , 2010, Science.

[32]  S. Liggett.  α2A-Adrenergic Receptors in the Genetics, Pathogenesis, and Treatment of Type 2 Diabetes , 2009, Science Translational Medicine.

[33]  G. Sumara,et al.  Regulation of PKD by the MAPK p38δ in Insulin Secretion and Glucose Homeostasis , 2009, Cell.

[34]  M. Hebrok,et al.  Pancreatic innervation in mouse development and β-cell regeneration , 2007, Neuroscience.

[35]  B. Ahrén,et al.  G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. , 2007, Pharmacology & therapeutics.

[36]  R. Knutsen,et al.  An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension. , 2007, Cell metabolism.

[37]  M. Atkinson.  Faculty Opinions recommendation of TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes. , 2007 .

[38]  Michael W. Salter,et al.  TRPV1+ Sensory Neurons Control β Cell Stress and Islet Inflammation in Autoimmune Diabetes , 2006, Cell.

[39]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[40]  Long Yu,et al.  BRSK2 is activated by cyclic AMP-dependent protein kinase A through phosphorylation at Thr260. , 2006, Biochemical and biophysical research communications.

[41]  P. Cryer.  Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes. , 2006, The Journal of clinical investigation.

[42]  J. Wess,et al.  A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. , 2006, Cell metabolism.

[43]  P. Cryer.  Diverse causes of hypoglycemia-associated autonomic failure in diabetes. , 2004, The New England journal of medicine.

[44]  Vassilios J. Bezzerides,et al.  Mechanism of persistent protein kinase D1 translocation and activation. , 2003, Developmental cell.

[45]  H. Utsumi,et al.  High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. , 2000, Diabetes.

[46]  B. Ahrén.  Autonomic regulation of islet hormone secretion – Implications for health and disease , 2000, Diabetologia.

[47]  M. Berthault,et al.  Lipid infusion lowers sympathetic nervous activity and leads to increased beta-cell responsiveness to glucose. , 1999, The Journal of clinical investigation.

[48]  C. Owyang,et al.  A newly cloned phospholipase A2-activating protein elicits Ca2+ oscillations and pancreatic amylase secretion via mediation of G protein beta/phospholipase A2/arachidonic acid cascades. , 1994, Biochemical and biophysical research communications.

[49]  J. Bomalaski,et al.  IL-1 increases phospholipase A2 activity, expression of phospholipase A2-activating protein, and release of linoleic acid from the murine T helper cell line EL-4. , 1992, Journal of immunology.

[50]  J. H. Schwartz,et al.  A phospholipase A2-stimulating protein regulated by protein kinase C in Aplysia neurons. , 1991, Brain research. Molecular brain research.

[51]  J. Miyazaki,et al.  Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. , 1990, Endocrinology.

[52]  P. Cryer,et al.  Direct muscarinic cholinergic inhibition of hepatic glucose production in humans. , 1988, The Journal of clinical investigation.

[53]  A. Clark,et al.  Neural control of the endocrine pancreas , 1987, Proceedings of the Nutrition Society.

[54]  B. Frier,et al.  Acute hypoglycemia in man: neural control of pancreatic islet cell function. , 1981, Metabolism: clinical and experimental.

[55]  C. W. Greene,et al.  THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY. , 1917, Science.

[56]  C. Chamberlain,et al.  Human pancreatic neuro-insular network in health and fatty infiltration , 2017, Diabetologia.

[57]  Jason K. Kim.  Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo. , 2009, Methods in molecular biology.

[58]  M. Hebrok,et al.  Pancreatic innervation in mouse development and beta-cell regeneration. , 2007, Neuroscience.

[59]  D. Dardevet,et al.  Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal. , 2006, American journal of physiology. Endocrinology and metabolism.

[60]  American Journal of Physiology- Endocrinology and Metabolism publishes results of original studies about , 2005 .

[61]  F. Sundler,et al.  Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. , 1997, Metabolism: clinical and experimental.